Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
real-world data
Pharma
Wegovy tops Zepbound on CV risk reduction in real-world study
In a real-world study, Wegovy cut the risk of heart attack, stroke and death by 57% in patients without treatment gaps compared to Lilly’s Zepbound.
Fraiser Kansteiner
Sep 2, 2025 11:33am
J&J's Erleada shows survival edge over Xtandi in real-world study
Oct 2, 2024 2:42pm
Ocaliva's fate looks bleak after FDA releases new briefing docs
Sep 11, 2024 4:58pm
Takeda, Eisai, US-China audit deal—Fierce Pharma Asia
Aug 26, 2022 10:10am
In a first, China approves eye implant based solely on RWD
Jun 21, 2022 11:22am
ICER is urging steep discounts on Takeda and CSL drugs
Aug 24, 2021 2:18pm
